Author:
Wang Sheng-Han,Yeh Shiou-Hwei,Chen Pei-Jer
Reference191 articles.
1. Abd El-Moneim E, Younis FA, Allam N, Gameel K, Osman M (2008) Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients. Egypt J Immunol/Egypt Assoc Immunol 15(2):125–134
2. Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O’Brien TR, Dienstag JL, Tanabe KK, Chung RT (2011) A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141(1):141–149. doi: 10.1053/j.gastro.2011.03.045
3. Ahmad J, Eng FJ, Branch AD (2011) HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core gene. Semin Liver Dis 31(4):347–355. doi: 10.1055/s-0031-1297924
4. Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G (2000) Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer 89(1):53–59
5. Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Arase Y, Ikeda K, Kumada H (2006) Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. J Med Virol 78(1):83–90. doi: 10.1002/jmv.20507
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献